A semimechanistic population pharmacokinetic and pharmacodynamic model incorporating autoinduction for the dose justification of TAS‐114
Abstract TAS‐114 is a dual deoxyuridine triphosphatase (dUTPase) and dihydropyrimidine dehydrogenase (DPD) inhibitor expected to widen the therapeutic index of capecitabine. Its maximum tolerated dose (MTD) was determined from a safety perspective in a combination study with capecitabine; however, i...
Wedi'i Gadw mewn:
Prif Awduron: | Hikari Araki (Awdur), Toru Takenaka (Awdur), Koichi Takahashi (Awdur), Fumiaki Yamashita (Awdur), Kazuaki Matsuoka (Awdur), Kunihiro Yoshisue (Awdur), Ichiro Ieiri (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
Wiley,
2022-05-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Population pharmacokinetic modeling of molibresib and its active metabolites in patients with solid tumors: A semimechanistic autoinduction model
gan: Anu Shilpa Krishnatry, et al.
Cyhoeddwyd: (2021) -
Semimechanistic pharmacokinetic-pharmacodynamic model of tripegfilgrastim for pediatric patients after chemotherapy
gan: Soyoung Lee, et al.
Cyhoeddwyd: (2023) -
Semimechanistic Pharmacodynamic Modeling of Aztreonam‐Avibactam Combination to Understand Its Antimicrobial Activity Against Multidrug‐Resistant Gram‐Negative Bacteria
gan: Alexia Chauzy, et al.
Cyhoeddwyd: (2019) -
Semimechanistic Modeling to Guide Venetoclax Coadministration with Ritonavir and Digoxin
gan: Ali A. Alhadab, et al.
Cyhoeddwyd: (2020) -
Bridging population pharmacokinetic and semimechanistic absorption modeling of APX3330
gan: Larissa L. Silva, et al.
Cyhoeddwyd: (2024)